Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5380-5391

  Castaño, Enrique ^a   Kleyner, Yelena ^a   Dynlacht, Brian David ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SEQUENCE; GROWTH INHIBITION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MAMMALIA;

EID: 0031865232     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.9.5380     Document Type: Article

References (45)

1. Adams, P. D., W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, and W. G. Kaelin. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16:6623-6633.
2. Beijersbergen, R. L., L. Carlee, R. M. Verkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9:1340-1353.
3. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179.
4. Chen, I.-T., M. Akamatsu, M. L. Smith, F.-D. T. Lung, D. Duba, P. P. Roller, A. J. Fornace, and P. M. O'Connor. 1996. Characterization of p21cip1/waf1 peptide domains required for cyclin E/cdk2 and PCNA interactions. Oncogene 12:595-607.
5. CIP1. Mol. Cell. Biol. 16:4673-4682.
6. Cobrinik, D., M.-H. Lee, G. Hannon, G. Mulligan, R. T. Bronson, N. Dyson, E. Harlow, D. Beach, R. A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
7. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding domain. Genes Dev. 7:2392-2404.
8. De Luca, A., T. K. MacLachlan, L. Bagella, C. Dean, C. M. Howard, P. P. Claudio, A. Baldi, K. Khalil, and A. Giordano. 1997. Unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J. Biol. Chem. 272: 20971-20974.
9. de Nooij, J. C., M. A. Letendre, and I. K. Hariharan. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87:1237-1247.
10. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
11. Du, W., M. Vidal, J.-E. Xie, and N. Dyson. 1996. A homologue of the retinoblastoma family of proteins regulates E2F activity in Drosophila. Genes Dev. 10:1206-1218.
12. Dynlacht, B. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389:149-152.
13. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2Ftrans-activation by cyclin-cdk2 complexes. Genes Dev. 8:1772-1786.
14. Dynlacht, B. D., K. Moberg, J. A. Lees, E. Harlow, and L. Zhu. 1997. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17:3867-3875.
15. Ewen, M., B. Faha, E. Harlow, and D. Livingston. 1992. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255:85-87.
16. Faha, B., M. Ewen, L.-H. Tsai, D. Livingston, and E. Harlow. 1992. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255:87-90.
17. Fotedar, R., P. Fitzgerald, T. Rouselle, D. Cannella, M. Doree, H. Messier, and A. Fotedar. 1996. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12: 2155-2164.
18. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
19. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
20. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
21. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
22. Hauser, P. J., D. Agrawal, B. Chu, and W. J. Pledger. 1997. p107 and p130 associated cyclin A has altered substrate specificity. J. Biol. Chem. 272: 22954-22959.
23. Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082-3089.
24. Hurford, R. K., D. Cobrinik, M.-H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
25. Krek, W., M. E. Ewen, S. Z. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
26. Lacy, S., and P. Whyte. 1997. Identification of a p130 domain mediating interactions with cyclin A/cdk2 and cyclin E/cdk2 complexes. Oncogene 14:2395-2406.
27. Lane, M. E., K. Sauer, K. Wallace, Y. N. Jan, C. F. Lehner, and H. Vaessin. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87:1225-1235.
28. Lee, M.-H., B. O. Williams, G. Mulligan, S. Mukai, R. T. Bronson, N. Dyson, E. Harlow, and T. Jacks. 1996. Targeted disruption of p 107: functional overlap between p107 and Rb. Genes Dev. 10:1621-1632.
29. Lees, E., B. F. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
30. Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
31. WAF activities. Mol. Cell. Biol. 16:1786-1793.
32. Mayol, X., X. Grana, A. Baldi, N. Sang, Q. Hu, and A. Giordano. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-2566.
33. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
34. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1013-1020.
35. Kip1. Genes Dev. 11:1464-1478.
36. Sherr, C., and J. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1153.
37. Shirodkar, S., M. Ewen, J. A. DeCaprio, D. Morgan, D. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
38. Smith, E., and J. R. Nevins. 1995. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol. Cell. Biol. 15:338-344.
39. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
40. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
41. Woo, M. S.-A., I. Sanchez, and B. D. Dynlacht. 1997. p130 and p107 use a conserved domain to regulate cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 17:3566-3579.
42. Zhu, L., G. Enders, J. A. Lees, R. L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14:1904-1913.
43. CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.
44. Zhu, L., G. H. Enders, C.-L. Wu, M. A. Starz, K. H. Moberg, J. A. Lees, N. Dyson, and E. Harlow. 1994. Growth suppression by members of the retinoblastoma protein family. Cold Spring Harbor Symp. Quant. Biol. 59:75-84.
45. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.